Get started
Author

Cosmas Rinaldi A. Lesmana

Observed names: Cosmas Rinaldi A Lesmana, Lesmana, Cosmas Rinaldi A., R. Lesmana
OpenAlex ID: A5068252279
APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update
2026 · Hong You, Rakhi Maiwall, et al. · Hepatology International · 7
PDF
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement
2026 · Chu-Tian Wu, Giovanni Targher, et al. · Gut · 5
PDF
A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper
2026 · Tao Chen, Ashok Choudhury, et al. · Hepatology International · 1
PDF
Delphi survey to explore core curriculum for training the next generation of hepatologists
2026 · Xinyi Xu, Yu Shi, et al. · JHEP Reports · 1
Metabolic Dysfunction-Associated Steatotic Liver Disease: An Update Narrative Review of the Therapeutic Potential of Combining Probiotics and Metformin
2026 · Syifa Mustika, Sri Utami, et al. · Biomedicines · 1
Aligning policy and clinical guidelines for albumin use in cirrhosis: insights from Indonesia Hepatology Medical Workgroup Meeting
2026 · Irsan Hasan, Andri Sanityoso Sulaiman, et al. · Translational Gastroenterology and Hepatology
Supplemental Material for: Curative Locoregional Therapy Following Objective Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
2026 · figshare admin karger, Yu-Yun Shao, et al. · Figshare
Curative Locoregional Therapy following Objective Response to Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
2026 · Yu-Yun Shao, San-Chi Chen, et al. · Liver Cancer
Case Report: Pancreatic toxoplasmosis: role of endoscopic ultrasound in diagnosis
2026 · Cosmas Rinaldi A. Lesmana, Randy Adiwinata, et al. · Frontiers in Gastroenterology
PDF
Sa2080 INTERIM ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL EVALUATING ELOBIXIBAT VS VITAMIN E FOR METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): EFFECTS ON STEATOSIS, LIVER STIFFNESS, AND METABOLIC PARAMETERS
2026 · Cosmas Rinaldi A. Lesmana, Sharon Sandra · Gastrointestinal Endoscopy
Sa2080 INTERIM ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL EVALUATING ELOBIXIBAT VS VITAMIN E FOR METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): EFFECTS ON STEATOSIS, LIVER STIFFNESS, AND METABOLIC PARAMETERS
2026 · Cosmas Rinaldi A. Lesmana, Sharon Sandra · Gastroenterology
Profil Klinis dan Kesintasan Pasien Karsinoma Sel Hati di Rumah Sakit Rujukan Tersier Indonesia Tahun 2015-2021
2023 · Hasan, Irsan, Gani, Rino Alvani, et al. · Jurnal Penyakit Dalam Indonesia
PDF
Tenofovir is more potent over entecavir in reducing the viral load in patients of hepatitis B reactivation presenting as Acute on Chronic Liver Failure (ACLF)-Results of multination study from APASL-ACLF Research Consortium (AARC)
2018 · J. Ahmad, A. Choudhury, et al. · Journal of Hepatology
Works count: 13
Citation count: 15
H-index: 2
I10-index:
Year
Topic
Type